Hyaluronic acid (HA) is a Glycosaminoglycan made of disaccharide units containing N-
acetyl-D-glucosamine and glucuronic acid. Its molecular mass can reach 10 MDa and its …

Glioblastoma multiforme (GBM) is the most common malignant brain tumor, associated with
low long-term survival. Nanoparticles (NPs) developed against GBM are a promising …

A drawback in the development of treatments that can reach the retina is the presence of
barriers in the eye that restrain compounds from reaching the target. Intravitreal injections …

Glioblastoma is the most common primary, malignant brain tumor that remains uniformly
lethal in nearly all cases as a result of extreme cellular heterogeneity, treatment resistance …

Enzyme‐based therapy has garnered significant attention for its current applications in
various diseases. Despite the notable advantages associated with the use of enzymes as …

Polymeric nanoparticles (PNPs) are a group of nanocarriers employed in a wide range of
applications. Characterization is a fundamental step in PNPs formulation and many basic …

Spinal cord injury (SCI) is characterized by a cascade of events that lead to sensory and
motor disabilities. To date, this condition is irreversible, and no cure exists. To improve …

Purpose In recent years, microfluidic technologies have become mainstream in producing
gene therapy nanomedicines (NMeds) following the Covid-19 vaccine; however, extensive …

Small interfering RNA (siRNA) holds great potential to treat many difficult-to-treat diseases,
but its delivery remains the central challenge. This study aimed at investigating the suitability …

Nanotechnologies, such as nanoparticles (NPs) and nanomedicines (NMeds), show great
promise for treating and diagnosing central nervous system diseases due to features like …